Table 2.
APM expression and CD8+ T cell infiltration in primary breast cancers with or without brain metastases
Without brain mets (N = 50) | With brain mets (N = 15) | P value* | |
---|---|---|---|
HLA | 0.81 ± 0.89 | 0.73 ± 1.02 | 0.61 |
β2m | 0.99 ± 0.90 | 0.23 ± 0.56 | <0.001 |
Tapasin | 0.91 ± 0.97 | 0.47 ± 0.61 | 0.13 |
TAP1 | 1.55 ± 0.90 | 0.43 ± 0.70 | <0.001 |
TAP2 | 0.72 ± 0.69 | 1.20 ± 0.88 | 0.061 |
LMP2 | 1.41 ± 0.73 | 1.37 ± 0.74 | 0.87 |
Calnexin | 1.99 ± 0.76 | 1.33 ± 1.10 | 0.03 |
CD8+ T cells/10HPF† | 130.04 ± 139.15 | 38.80 ± 50.54 | <0.001 |
Data indicate mean scores ± SD
* Mann–Whitney U test. Bold: Statistically significant (P < 0.05)
† HPF high power field